{
    "code": "02025504",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025504",
    "time": "2020-02-25 13:37:31",
    "許可證字號": "衛署藥輸字第025504號",
    "註銷狀態": "已註銷",
    "註銷日期": "106\/05\/08",
    "註銷理由": "屆期未申請展延",
    "製造許可登錄編號": "",
    "有效日期": "105\/08\/16",
    "發證日期": "100\/08\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202550406",
    "中文品名": "抑畢癌靜脈注射液2毫克\/毫升",
    "英文品名": "Epirubicin-Teva 2mg\/ml, solution for infusion",
    "適應症": "乳腺癌、惡性淋巴瘤、軟組織肉瘤、胃癌、肺癌、卵巢瘤。",
    "劑型": "270注射劑",
    "包裝": "5,25毫升小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "EPIRUBICIN HCL",
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
    "申請商名稱": "1011101100  海喬國際股份有限公司",
    "申請商地址": "台北市大同區重慶北路三段276號9樓",
    "主製造廠": [
        {
            "製造廠名稱": "FNL0029100  PHARMACHEMIE B.V.",
            "製造廠廠址": "SWENSWEG 5,2031 GA HAARLEM,THE NETHERLANDS",
            "製造廠公司地址": "P.O.BOX 552, 2003 RN HAARLEM,THE NETHERLANDS",
            "製造廠國別": "NETHERLANDS",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012000910",
            "成分名稱": "EPIRUBICIN HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020255040023___20111005.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025504&Seq=023&Type=9"
        },
        {
            "title": "020255040005___20111005.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025504&Seq=005&Type=8"
        }
    ]
}